251P The effect of hormone receptor positive percentage on treatment response and prognosis in HR+ HER2- metastatic breast cancer receiving CDK 4/6 inhibitor + endocrine treatment
| Autor: | Keskinkilic, M. 1, Semiz, H.S. 2, Yavuzsen, T. 2, Oztop, I. 3 |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|